Skip to main content
Premium Trial:

Request an Annual Quote

SAIC-Frederick, Roche Team on NCI Sequencing Project

NEW YORK (GenomeWeb News) – SAIC-Frederick and Roche Applied Science will collaborate to test Roche's sequence capture and sequencing technologies for use in research projects for the National Cancer Institute, Roche Diagnostics said today.

A contractor for NCI, SAIC-Frederick will use the NimbleGen Sequence Capture technology, along with the Genome Sequencer FLX from Roche's 454 Life Sciences business, to conduct targeted re-sequencing for cancer genomics studies.

Under NCI's Advanced Technology Partnerships Initiative, SAIC-Frederick will assess how Roche NimbleGen's SeqCap EZ system works to capture specific regions of the genome of a cancer research sample. That captured DNA will then be re-sequenced using the FLX system in an effort to identify genetic variants that contribute to cancer outcomes, Roche said.

"Our intent is to implement Roche NimbleGen's solution-based sequence capture technology, SeqCap EZ, to rapidly advance our next-generation sequencing projects and in turn, increase our knowledge of cancer genetics," said Joseph Boland, who is dedicated scientific operations manager of SAIC-Frederick's Core Genotyping Facility.

Financial terms of the agreement were not released.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.